Ledger.Open graph →
SEC Form D · filed February 18, 2021

Silence Therapeutics plc

Offering
$45.5M
Sold
$45.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Dave Lemus · London, United KingdomDirectorJames Ede-Golightly · London, United KingdomDirectorAlistair Gray · London, United KingdomDirectorCraig Tooman · Kansas City, KSExecGiles Campion · Leiden, P7ExecRomano Steven · London, United KingdomDirectorMichael H. Davidson · London, United KingdomDirectorMark Rothera · London, United KingdomExec · DirectorIain Ross · San Francisco, CADirectorBarbara Ruskin · London, United KingdomExecJames Ede-Golightly · London, United KingdomDirectorAlistair Gray · London, United KingdomDirectorCraig Tooman · London, United KingdomExecDave Lemus · London, United KingdomDirectorGiles Campion · Leiden, P7ExecRomano Steven · London, United KingdomDirectorMichael H. Davidson · London, United KingdomDirectorMark Rothera · London, United KingdomExec · DirectorIain Ross · San Francisco, CADirectorBarbara Ruskin · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗